arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Grace Therapeutics, Inc.

GRCE Health Care Biotechnology: Pharmaceutical Preparations
$1.90
▼ -3.8% Today
as of Oct 23, 11:48 ET
Last 30 days -17.03% Sep 14 → Oct 23
$1.85 $1.97 $2.08 $2.20 $2.32 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$1.91
High
$1.93
Low
$1.87
Volume
$97,096
Avg Vol
$304,323
Mkt Cap
$43M
P/E (TTM)
—
Beta
—
52w High
$5.18
52w Low
$1.79
Div Yield
—
Shares Out
$16M

Recent Press Releases & News last 60 days · 2 items

Sep 3 · 12:00 PR GlobeNewswire
Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference
Aug 24 · 20:40 MT Newswires
Grace Therapeutics Files for Resale of Up to 4.8 Million Shares

GRCE earnings at a glance

The options market is pricing a move of about ±14.2% after the report, a range of roughly $1.63 to $2.17 from today's $1.90. Over its last 1 reports the stock rose the next day 0 times and fell 1, moving ±2.3% on average; after the most recent report on Jun 23, 2025 it moved -2.3%. That means options currently expect more movement than GRCE has typically delivered. GRCE beat the consensus EPS estimate in 1 of its last 3 reported quarters. Implied volatility is currently 80%. The share price of $1.90 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$1.79
$5.18
3% of range
Avg surprise (last 3)
+10.5%
Avg reaction (last 1)
-2.3%
0% positive
Latest IV / EM
80%
EM ±14.2% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.91$-0.70$-0.48$-0.27$-0.05 Actual $-0.52Actual $-0.05Est $-0.13Actual $-0.43Actual $-0.21Actual $-0.24Actual $-0.30Actual $-0.36Actual $-0.21Est $-0.20Actual $-0.21Actual $-0.15Est $-0.12Actual $-0.14Actual $-0.91 DecMar/2023SepDecJunSepDecMar/2025Jun/2025Sep/2025DecJun
Revenue vs Net Income Revenue Net income
$-16M$-12M$-8M$-5M$-984,900 Sep 24Dec 24Jun 25Sep 25Dec 25Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.91 — — — — financials
Wed Dec 31, 2025Dec 2025 $-0.14 — — — — financials
Thu Nov 13, 2025Sep/2025 $-0.15 $-0.12 -25.0% — — earnings
Tue Aug 12, 2025Jun/2025 $-0.21 — — — — earnings
Mon Jun 23, 2025Mar/2025 $-0.21 $-0.20 -5.0% — -2.3% earnings
Tue Dec 31, 2024Dec 2024 $-0.36 — — — — financials
Mon Sep 30, 2024Sep 2024 $-0.30 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.24 — — — — financials
Sun Dec 31, 2023Dec 2023 $-0.21 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.43 — — — — financials
Fri Jun 23, 2023Mar/2023 $-0.05 $-0.13 +61.5% — — earnings
Sat Dec 31, 2022Dec 2022 $-0.52 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-16M—$-2M$-3M$-3M—$-4M$-5M
Net income$-16M—$-2M$-938,000$-3M—$-4M$-3M
EPS (diluted)$-0.91—$-0.14$-0.06$-0.21—$-0.36$-0.30

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$14M$17M$19M$17M$2M$22M$836,000$1M
Inventory————————
Total current assets$14M$17M$19M$17M$21M$23M$12M$16M
Total assets$50M$67M$68M$67M$70M$72M$61M$65M
Long-term debt————————
Total liabilities$2M$3M$4M$4M$6M$5M$9M$9M
Total equity$48M$64M$65M$63M$64M$67M$52M$56M

Implied volatility — last 90 days

32%319%605%892%1178% Jun 06 — IV 77% · EM ±13.6%Jun 07 — IV 78% · EM ±10.9%Jun 08 — IV 82% · EM ±10.9%Jun 09 — IV 51% · EM ±6.4%Jun 10 — IV 55% · EM ±6.5%Jun 22 — IV 106% · EM ±22.1%Jun 23 — IV 61% · EM ±12.6%Jun 24 — IV 107% · EM ±21.5%Jun 26 — IV 66% · EM ±12.6%Jun 29 — IV 61% · EM ±10.9%Jun 30 — IV 65% · EM ±11.2%Jul 06 — IV 57% · EM ±7.9%Jul 07 — IV 60% · EM ±8.0%Jul 08 — IV 62% · EM ±7.8%Jul 20 — IV 96% · EM ±22.6%Jul 21 — IV 80% · EM ±18.5%Jul 22 — IV 74% · EM ±16.9%Jul 23 — IV 71% · EM ±16.0%Jul 24 — IV 78% · EM ±17.2%Jul 27 — IV 135% · EM ±28.3%Jul 28 — IV 152% · EM ±31.1%Jul 29 — IV 138% · EM ±27.6%Jul 30 — IV 142% · EM ±27.8%Jul 31 — IV 239% · EM ±45.7%Aug 03 — IV 258% · EM ±45.7%Aug 04 — IV 226% · EM ±39.0%Aug 05 — IV 237% · EM ±39.5%Aug 06 — IV 262% · EM ±42.5%Aug 07 — IV 240% · EM ±37.6%Aug 10 — IV 274% · EM ±37.9%Aug 11 — IV 1179% · EM ±155.7%Aug 12 — IV 304% · EM ±38.1%Aug 13 — IV 409% · EM ±48.3%Aug 14 — IV 335% · EM ±37.0%Aug 17 — IV 416% · EM ±34.7%Aug 18 — IV 519% · EM ±37.6%Aug 19 — IV 539% · EM ±31.8%Aug 20 — IV 783% · EM ±32.7%Aug 24 — IV 33% · EM ±6.9%Aug 25 — IV 34% · EM ±6.9%Sep 09 — IV 1119% · EM ±140.2%Sep 11 — IV 183% · EM ±20.3%Sep 21 — IV 901% · EM ±188.1%Sep 22 — IV 183% · EM ±37.4%Sep 23 — IV 183% · EM ±36.6%Sep 24 — IV 189% · EM ±37.0%Sep 25 — IV 49% · EM ±9.4%Sep 28 — IV 80% · EM ±14.2%

Sector peers

VERU
Veru Inc.
$44M $2.27-1.3%
HOWL
Werewolf Therapeutics, Inc.
$45M $1.02-0.5%
NSRX
Nasus Pharma Ltd.
$40M $3.51+14.7%
EDSA
Edesa Biotech, Inc.
$46M $2.72-4.6%
FLNA
Filana Therapeutics, Inc.
$47M $0.64-2.4%
IBO
Impact BioMedical, Inc.
$38M $3.66-9.0%

GRCE earnings FAQ

What is GRCE's expected move for earnings?

Options currently price a move of about ±14.2%, or $0.27 per share either way from $1.90.

How does GRCE stock usually react to earnings?

Across the last 1 reports the average next-day move was ±2.3%, up 0 times and down 1 times.

What is GRCE's implied volatility?

GRCE's at-the-money implied volatility is about 80% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in